Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

SLNSLN
Showing 8 of 10 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in Silence Therapeutics PLC Sponsored ADR

TWO SIGMA INVESTMENTS, LP holds 121,004 shares of SLN (Silence Therapeutics PLC Sponsored ADR), worth $1.3M as of 2026-Q2. The position was increased (+646.8% shares). SLN represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$1.3M

Current Shares

121,004

Total Value Change

-$1.8M

Total Shares Change

-48,388

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
121,004
+646.8%
$1.3M0.0%$10.98
41
2026-Q1
Decreased
16,203
-58.8%
$85,3900.0%$5.66
0
2025-Q4
Decreased
39,344
-37.8%
$239,2120.0%$6.15
0
2025-Q3
Increased
63,247
+6.6%
$328,2520.0%$5.67
25
2025-Q2
Decreased
59,312
-22.0%
$344,0100.0%$5.79
0
2025-Q1
Decreased
76,008
-46.5%
$214,3430.0%$3.44
0
2024-Q4
Decreased
142,052
-16.1%
$977,3180.0%$6.91
0
2024-Q3
Increased
169,392
+70.9%
$3.1M0.0%$18.25
39

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used